Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biogena Group Invest AGWBO:BIO -1.87%60 PS Ratio is 59.66 as of Jul. 29, 2026, which is 82% above its 10-year median of 32.80. GuruFocus rates WBO:BIO with a GF Score™ of 60/100 and a GF Value™ of €3.48 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,940 Consumer Packaged Goods companies, Biogena Group Invest AG ranks worse than 98.81% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Biogena Group Invest AG's share price is €5.25.
Biogena Group Invest AG's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 was €0.09. Hence, Biogena Group Invest AG's PS Ratio for today is 59.66.
Warning Sign:
Biogena Group Invest AG stock PS Ratio (=60.8) is close to 10-year high of 60.8.
The historical rank and industry rank for Biogena Group Invest AG's PS Ratio or its related term are showing as below:
WBO:BIO'
s PS Ratio Range Over the Past 10 Years
Min: 14.79 Med: 32.8 Max: 60.8
Current: 59.66
During the past 7 years, Biogena Group Invest AG's highest PS Ratio was 60.80. The lowest was 14.79. And the median was 32.80.
WBO:BIO's PS Ratio is ranked worse than 98.81% of 1940
companies
in the Consumer Packaged Goods industry
Industry Median: 0.85
vs WBO:BIO: 59.66
During the past 7 years, Biogena Group Invest AG's highest 3-Year average Revenue per Share Growth Rate was 11.80% per year. The lowest was -36.60% per year. And the median was 3.50% per year.
Back to Basics: PS Ratio
Biogena Group Invest AG (WBO:BIO) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Biogena Group Invest AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogena Group Invest AG PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Biogena Group Invest AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Biogena Group Invest AG's Share Price of today is €5.25.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Biogena Group Invest AG's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 was €0.09.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Biogena Group Invest AG (WBO:BIO) has a PS Ratio of 59.66 as of Jul. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Biogena Group Invest AG and its competitors. This is 82% above median its historical median of 32.80. Over the past decade, Biogena Group Invest AG's PS Ratio has ranged from 14.79 to 60.80. According to the industry distribution chart, Biogena Group Invest AG ranks #1917 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 98.8%.
Is Biogena Group Invest AG's PS Ratio too high?
Biogena Group Invest AG's current PS Ratio of 59.66 is 82% above median its 10-year median of 32.80. Over the past 10 years, this metric has ranged from a low of 14.79 to a high of 60.80. The Consumer Packaged Goods industry median PS Ratio is 0.85. Biogena Group Invest AG's value of 59.66 is 6918.8% above this industry median. Based on the distribution chart, Biogena Group Invest AG ranks #1917 out of 1940 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Biogena Group Invest AG has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's PS Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biogena Group Invest AG ranks #1917 out of 1940 companies for PS Ratio. This places Biogena Group Invest AG in the lower half of its industry. The industry median PS Ratio is 0.85. Biogena Group Invest AG's value of 59.66 is 6918.8% above this benchmark. Historically, Biogena Group Invest AG's own PS Ratio has ranged from 14.79 to 60.80 over the past decade. While the company's 10-year median is 32.80 vs. the industry median of 0.85, Biogena Group Invest AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.85, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biogena Group Invest AG's current PS Ratio of 59.66 is 6918.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Biogena Group Invest AG and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biogena Group Invest AG's current PS Ratio is 59.66, which is 82% above median its own 10-year median of 32.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.48, compared to a current price of €5.25 — trading 50.9% above its estimated fair value. The current PS Ratio is 59.66, which is 82% above median its 10-year median of 32.80 and 6918.8% above the Consumer Packaged Goods industry median of 0.85. Biogena Group Invest AG's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current PS Ratio is 59.66 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued.
The current stock price of €5.25 is trading 50.9% above its estimated GF Value™ of €3.48.
GuruFocus considers Biogena Group Invest AG to be Significantly Overvalued.
Key valuation signals for WBO:BIO:
PS Ratio: 59.66 (82% above median its 10-year median of 32.80)
GF Value™: €3.48 vs. price of €5.25 (50.9% above fair value)
Industry Position: 6918.8% above the Consumer Packaged Goods median (#1917 of 1940)
No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
60GF Score
Get the complete analysis for WBO:BIO
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BIO has been successfully added to your 
